The Sustained Release Excipients market is a subset of the Pharmaceutical Intermediates market. It is composed of excipients used to modify the release of active pharmaceutical ingredients (APIs) over a period of time. These excipients are used to improve the bioavailability of APIs, reduce the frequency of dosing, and improve patient compliance. They are also used to reduce the risk of side effects and improve the stability of APIs. Common excipients used in sustained release formulations include polymers, lipids, and surfactants. Companies in the Sustained Release Excipients market include BASF, Evonik, Ashland, Colorcon, Dow, Lubrizol, and Roquette. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.